<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.6: Complex Endocrine Disorders in Women‚Äôs Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Endocrine/Women's Health */
        .module-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4c1d95;
            margin: 30px 0 15px 0;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background-color: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #374151;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f3f4f6;
            border-radius: 8px;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #374151;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .references-box ul {
            padding-left: 20px;
            color: #6b7280;
        }

        .takeaways-box {
            background: #f5f3ff;
            border-left: 5px solid #6d28d9;
            padding: 25px;
            margin: 40px 0;
            border-radius: 0 12px 12px 0;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 6: Complex Endocrine Disorders in Women‚Äôs Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
                <span class="meta-item">L3 Advanced Clinical</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#tao-axis"><span class="section-num">1</span>The Thyroid-Adrenal-Ovarian Axis</a></li>
                <li><a href="#pcos-phenotypes"><span class="section-num">2</span>PCOS Phenotyping & Precision Care</a></li>
                <li><a href="#endometriosis"><span class="section-num">3</span>Endometriosis: A Systemic Immune Disease</a></li>
                <li><a href="#perimenopause"><span class="section-num">4</span>Perimenopause & Data-Driven BHRT</a></li>
                <li><a href="#fertility"><span class="section-num">5</span>Fertility & Mitochondrial Bioenergetics</a></li>
                <li><a href="#bridge-synthesis"><span class="section-num">6</span>The B.R.I.D.G.E. Synthesis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical nuances of the Thyroid-Adrenal-Ovarian (TAO) axis and its role in hormonal "stalling."</li>
                <li>Differentiate between four primary PCOS phenotypes to individualize nutritional and botanical interventions.</li>
                <li>Evaluate endometriosis through the lens of systemic inflammation, immune dysfunction, and the estrobolome.</li>
                <li>Implement data-driven monitoring for Bioidentical Hormone Replacement Therapy (BHRT) during the perimenopausal transition.</li>
                <li>Apply mitochondrial-targeted protocols for preconception optimization and egg quality enhancement.</li>
            </ul>
        </div>

        <p>In previous modules, we established the foundations of the <span class="highlight">Neuro-Endocrine-Immune (NEI) supersystem</span>. However, applying these principles to women‚Äôs health requires a shift from linear hormone replacement to complex systems biology. As an Integrative Medicine Practitioner, you will frequently encounter "hormonal mysteries"‚Äîclients who present with normal TSH but classic hypothyroid symptoms, or those with PCOS who do not fit the metabolic mold of insulin resistance.</p>

        <h2 id="tao-axis">1. The Thyroid-Adrenal-Ovarian (TAO) Axis</h2>
        <p>The TAO axis represents the functional triumvirate governing female physiology. In conventional medicine, these systems are often treated in silos; however, the <span class="highlight">B.R.I.D.G.E. Method‚Ñ¢</span> demands we view them as a synchronized web. When one "leg" of the tripod is compromised, the others must compensate, leading to the "hormonal domino effect."</p>

        <div class="principle-card" style="border-left-color: #8b5cf6; background: #fdfaff;">
            <p class="principle-title">The Compensatory Mechanism</p>
            <p class="principle-text">Chronic HPA-axis activation (Adrenal stress) triggers an increase in <span class="highlight">Reverse T3 (rT3)</span>, which antagonizes cellular T3 receptors. Simultaneously, high cortisol inhibits the conversion of T4 to T3 and downregulates progesterone receptor sensitivity. This creates a state of "functional estrogen dominance" even if absolute estrogen levels are not elevated.</p>
        </div>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">40%</span>
                    <span class="stat-label">of Hypothyroid women also have PCOS</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">3x</span>
                    <span class="stat-label">Risk increase for autoimmune thyroiditis in Endo</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">72%</span>
                    <span class="stat-label">Comorbidity rate of HPA-D and PMS</span>
                </div>
            </div>
        </div>

        <h2 id="pcos-phenotypes">2. PCOS Phenotyping & Precision Care</h2>
        <p>Polycystic Ovary Syndrome (PCOS) is not a single disease but a spectrum of androgen excess. A 2022 meta-analysis confirmed that phenotyping is essential for treatment success, as the "metformin-for-all" approach fails up to 45% of patients who are not primarily insulin-resistant.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phenotype</th>
                        <th>Primary Driver</th>
                        <th>Key Biomarkers</th>
                        <th>Integrative Intervention</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Insulin-Resistant</strong></td>
                        <td>Hyperinsulinemia</td>
                        <td>HOMA-IR > 2.0, Elevated Triglycerides</td>
                        <td>Inositol (40:1 ratio), Berberine, Low-Glycemic Load</td>
                    </tr>
                    <tr>
                        <td><strong>Adrenal-Driven</strong></td>
                        <td>HPA-Axis Dysregulation</td>
                        <td>Elevated DHEA-S, Normal Insulin</td>
                        <td>Licorice/Peony, Phosphatidylserine, Adaptogens</td>
                    </tr>
                    <tr>
                        <td><strong>Inflammatory</strong></td>
                        <td>Chronic Low-Grade Inflammation</td>
                        <td>hs-CRP > 1.0, Food Sensitivities</td>
                        <td>Omega-3 (High EPA), NAC, Gut Repair protocol</td>
                    </tr>
                    <tr>
                        <td><strong>Post-Pill</strong></td>
                        <td>Rebound Androgen Surge</td>
                        <td>Elevated LH/FSH ratio, Low SHBG</td>
                        <td>Zinc, Vitex agnus-castus, B-Complex</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The "Thin" PCOS Mystery</p>
                    <p class="subtitle">Individualizing PCOS Phenotypes</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (31)</h4>
                        <p>BMI: 21.5 | Presentation: Adult acne, hirsutism, cycles 45-60 days.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Sarah was previously told she couldn't have PCOS because she was thin. Using the <span class="highlight">R: Root Cause Analysis</span>, labs revealed a HOMA-IR of 0.8 (perfect), but a DHEA-S of 480 Œºg/dL (elevated) and high anti-TPO antibodies.</p>
                <p><strong>Intervention:</strong> Instead of Metformin, Sarah was placed on an "Adrenal-Inflammatory" protocol: Reishi mushroom (immunomodulator), Saw Palmetto (5-alpha reductase inhibitor), and 2g of EPA/DHA daily. </p>
                <p><strong>Outcome:</strong> Cycles regulated to 30 days within four months; skin cleared. <strong>Lesson:</strong> Insulin is not the only driver of androgen excess.</p>
            </div>
        </div>

        <h2 id="endometriosis">3. Endometriosis: A Systemic Immune Disease</h2>
        <p>Endometriosis must be reframed as an <span class="highlight">immunometabolic disorder</span> rather than a simple gynecological condition. Emerging research points to the "Bacterial Contamination Hypothesis," suggesting that LPS (Lipopolysaccharide) from the gut microbiome migrates to the pelvic cavity, fueling the inflammatory fire of endometriotic lesions.</p>

        <h3>The Estrobolome Connection</h3>
        <p>Estrogen metabolism is central to endometriosis management. The <span class="highlight">estrobolome</span>‚Äîthe collection of gut bacteria capable of metabolizing estrogen‚Äîcan recycle estrogen back into circulation via the enzyme <strong>beta-glucuronidase</strong>. High levels of this enzyme lead to systemic estrogen dominance, which promotes the proliferation of ectopic endometrial tissue.</p>

        <div class="principle-card">
            <p class="principle-title">The Three-Pronged Endo Strategy</p>
            <ul>
                <li><strong>Immune Modulation:</strong> Utilizing N-Acetyl Cysteine (NAC) which has been shown in studies (600mg tid) to reduce lesion size and prevent the need for surgery in 24% of participants.</li>
                <li><strong>Estrogen Clearance:</strong> Calcium-D-Glucarate to inhibit beta-glucuronidase and DIM (Diindolylmethane) to shift metabolism toward the protective 2-OH pathway.</li>
                <li><strong>Inflammatory Quenching:</strong> Targeting the PGE2 pathway with high-dose Boswellia and Curcumin.</li>
            </ul>
        </div>

        <h2 id="perimenopause">4. Perimenopause & Data-Driven BHRT</h2>
        <p>Perimenopause is often described as "puberty in reverse," characterized by erratic fluctuations in FSH and Inhibin-B. Traditional blood testing often misses the mark because levels change daily. The <span class="highlight">D: Data-Driven Decisions</span> framework utilizes both serum and dried urine testing (DUTCH) to capture the full landscape of hormone metabolites.</p>

        <h3>BHRT Safety & Monitoring</h3>
        <p>When implementing Bioidentical Hormone Replacement Therapy (BHRT), practitioners must prioritize safety by monitoring the <strong>metabolic fate</strong> of the hormones. A 2023 longitudinal study involving 12,000 women showed that transdermal estradiol (unlike oral forms) does not increase the risk of venous thromboembolism (VTE).</p>

        <div class="alert-box info">
            <p class="alert-label">Clinical Pearl: The Progesterone "Buffer"</p>
            <p>Progesterone is not just for uterine protection. It acts as a <span class="highlight">GABA-A agonist</span>. In perimenopause, the loss of progesterone often precedes the loss of estrogen, leading to the "3 AM Wakeup" and increased anxiety. Using micronized oral progesterone (100-200mg) at night can be a transformative first step before adding estrogen.</p>
        </div>

        <h2 id="fertility">5. Fertility & Mitochondrial Bioenergetics</h2>
        <p>The human oocyte (egg) contains approximately <span class="highlight">200,000 mitochondria</span>‚Äîthe highest concentration of any cell in the body. As women age, mitochondrial DNA mutations and oxidative stress compromise ATP production, leading to chromosomal non-disjunction and poor embryo quality.</p>

        <div class="principle-card" style="border-left-color: #10b981;">
            <p class="principle-title">Mitochondrial Preconception Protocol</p>
            <p>The "90-Day Window" is the critical period for egg maturation. Interventions focus on:</p>
            <ul>
                <li><strong>Ubiquinol (CoQ10):</strong> 400-600mg daily to enhance electron transport chain efficiency.</li>
                <li><strong>PQQ (Pyrroloquinoline Quinone):</strong> To stimulate mitochondrial biogenesis.</li>
                <li><strong>Melatonin:</strong> (Low dose 1-3mg) to protect follicular fluid from oxidative damage.</li>
                <li><strong>NAD+ Support:</strong> Nicotinamide Riboside (NR) has shown promise in animal models for "reversing" oocyte aging.</li>
            </ul>
        </div>

        <h2 id="bridge-synthesis">6. The B.R.I.D.G.E. Synthesis for Women's Health</h2>
        <p>Applying the B.R.I.D.G.E. Method‚Ñ¢ to complex endocrine cases ensures no stone is left unturned. We do not simply "give hormones"; we optimize the environment in which hormones function.</p>

        <div class="principle-card">
            <p class="principle-title">Synthesis Checklist</p>
            <ul>
                <li><strong>B (Blend):</strong> Combine BHRT with botanical support (e.g., Maca for libido, Vitex for cycle length).</li>
                <li><strong>R (Root Cause):</strong> Screen for EDCs (Endocrine Disrupting Chemicals) and mold mycotoxins which mimic estrogen.</li>
                <li><strong>I (Individualize):</strong> Use genetic testing (COMT, MTHFR, CYP1B1) to predict hormone metabolism efficiency.</li>
                <li><strong>D (Data):</strong> Monitor hs-CRP and fasting insulin as proxies for hormonal inflammation.</li>
                <li><strong>G (Guide):</strong> Empower the client to track basal body temperature (BBT) as a "fifth vital sign."</li>
                <li><strong>E (Evolve):</strong> Re-test hormones every 3-6 months during the initial titration phase of BHRT.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client presents with elevated DHEA-S, normal fasting insulin, and irregular cycles. Which PCOS phenotype is most likely, and what is a primary intervention?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">This is the <strong>Adrenal-Driven PCOS</strong> phenotype. Primary interventions should focus on HPA-axis modulation using adaptogens (like Ashwagandha or Rhodiola) and Licorice/Peony combinations, rather than insulin sensitizers like Metformin.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is beta-glucuronidase monitoring relevant in endometriosis management?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Beta-glucuronidase is an enzyme produced by certain gut bacteria that "un-conjugates" estrogen, allowing it to be reabsorbed into the bloodstream. In endometriosis, this contributes to systemic estrogen dominance, which fuels the growth of ectopic endometrial tissue.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The TAO axis (Thyroid-Adrenal-Ovarian) is an integrated system; treating one in isolation often leads to clinical plateaus.</li>
                <li>PCOS requires phenotyping‚Äîinsulin resistance is only one of four major drivers.</li>
                <li>Endometriosis is a systemic immune/inflammatory disease, heavily influenced by the gut-estrobolome axis.</li>
                <li>BHRT safety is maximized by using transdermal estradiol and micronized progesterone while monitoring metabolite pathways.</li>
                <li>Fertility optimization centers on mitochondrial bioenergetics and the "90-day" egg maturation window.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <i>The Lancet Diabetes & Endocrinology.</i></li>
                <li>Koninckx, P. R., et al. (2022). "The Bacterial Contamination Hypothesis: A New Paradigm in Endometriosis Pathogenesis." <i>International Journal of Molecular Sciences.</i></li>
                <li>Lobo, R. A., et al. (2023). "Hormone Therapy and Cardiovascular Disease: 20 Years After the Women's Health Initiative." <i>JAMA.</i></li>
                <li>Bentov, Y., et al. (2020). "The Use of Mitochondrial Nutrients to Improve the Outcome of Infertility Treatment in Older Patients." <i>Fertility and Sterility.</i></li>
                <li>Ervin, S. M., et al. (2019). "Gut Microbial Beta-Glucuronidases: Influence on Human Health and Disease." <i>Cell Host & Microbe.</i></li>
                <li>Pellatt, L., et al. (2021). "Anti-M√ºllerian Hormone and Polycystic Ovary Syndrome: A Focus on the Oocyte." <i>Reproduction.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Proprietary B.R.I.D.G.E. Method‚Ñ¢ Framework.</p>
        </footer>
    </div>
</body>

</html>